ImmuCell Corporation Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31)
ImmuCell Corporation (ICCC) reported Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) of $0 for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-14.
Discontinued › Expense Statement › Income Tax
us-gaap:TaxBenefitFromStockOptionsExercised1 · last filed 2013-05-14
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-12-31 was $419.00, a 55.89% decline year-over-year.
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for the quarter ending 2012-06-30 was $0.00.
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2012 was $7.26K, a 49.99% decline from fiscal 2011.
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2011 was $14.52K.
- ImmuCell Corporation tax benefit from stock options exercised (deprecated 2013-01-31) for fiscal 2010 was $0.00.
| Period end | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 3 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 6 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 9 month | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) 12 month |
|---|---|---|---|---|
| 2013-03-31 | $0.00 10-Q · filed 2013-05-14 | $419.00 derived: sum of 2 quarters · filed 2013-05-14 | $419.00 derived: sum of 3 quarters · filed 2013-05-14 | $419.00 derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-12-31 | $419.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $419.00 derived: sum of 2 quarters · filed 2013-03-28 | $419.00 derived: sum of 3 quarters · filed 2013-03-28 | $7.26K 10-K · filed 2013-03-28 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | $6.84K 10-Q · filed 2012-11-13 | $7.79K derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $6.84K 10-Q/A · filed 2012-09-07 | $7.79K derived: sum of 3 quarters · filed 2013-05-14 | $13.96K derived: sum of 4 quarters · filed 2013-05-14 |
| 2012-03-31 | $6.84K 10-Q · filed 2013-05-14 | $7.79K derived: sum of 2 quarters · filed 2013-05-14 | $13.96K derived: sum of 3 quarters · filed 2013-05-14 | |
| 2011-12-31 | $950.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $7.11K derived: sum of 2 quarters · filed 2013-03-28 | $14.52K 10-K · filed 2013-03-28 | |
| 2011-09-30 | $6.16K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $13.57K 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | $7.40K 10-Q/A · filed 2012-09-07 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |